검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | Triamcinolone Acetonide |
Overview Company | Wei-Che Ko |
Overview Modality | ANTIBODY |
Overview Target | Diabetic Macular Edema |
Overview Indication | Skin Inflammation; Allergic Contact Dermatitis |
Overview Phase | PHASE_3 |
Overview Status | RECRUITING |
MoA Mechanism | targeting of STING-TBK1 signaling |
MoA Biomarker | biomarkers have shown that both TA and DEX implant are effective in promoting scattered punctate and plaque-l |
PK/PD Species | Rabbit |
PK/PD Animal (cat.) | Unknown |
PK/PD Experiment | pd |
Toxicology Species | Rabbit |
Toxicology Animal (cat.) | Unknown |
Toxicology Major finding | Corticosteroids for the treatment of diabetic macular edema with massive hard exudates: An evidence-based update.. Diabetic macular edema (DME) often presents with scattered punctate or massive hard exudates (HE), which can lead to visual acuity impairment. Plaque-like HE, a special type of massive HE, are even an independent risk factor for subfoveal fibrosis. Therefore, the elimination of HE is … |
Clinical Primary efficacy | ORR 9.8% |
Clinical ORR | 9.8% |
Clinical Result source | ClinicalTrials.gov NCT03520387 |
Clinical Data Tier / Score | A · 45 |
Clinical Program phase | PHASE_3 |
Clinical Clinical sync | 2026년 7월 12일 (1일 전) |
검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일
현재 선택: 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | Triamcinolone Acetonide |
Overview Company | Wei-Che Ko |
Overview Modality | ANTIBODY |
Overview Target | Diabetic Macular Edema |
Overview Indication | Skin Inflammation; Allergic Contact Dermatitis |
Overview Phase | PHASE_3 |
Overview Status | RECRUITING |
MoA Mechanism | targeting of STING-TBK1 signaling |
MoA Biomarker | biomarkers have shown that both TA and DEX implant are effective in promoting scattered punctate and plaque-l |
PK/PD Species | Rabbit |
PK/PD Animal (cat.) | Unknown |
PK/PD Experiment | pd |
Toxicology Species | Rabbit |
Toxicology Animal (cat.) | Unknown |
Toxicology Major finding | Corticosteroids for the treatment of diabetic macular edema with massive hard exudates: An evidence-based update.. Diabetic macular edema (DME) often presents with scattered punctate or massive hard exudates (HE), which can lead to visual acuity impairment. Plaque-like HE, a special type of massive HE, are even an independent risk factor for subfoveal fibrosis. Therefore, the elimination of HE is … |
Clinical Primary efficacy | ORR 9.8% |
Clinical ORR | 9.8% |
Clinical Result source | ClinicalTrials.gov NCT03520387 |
Clinical Data Tier / Score | A · 45 |
Clinical Program phase | PHASE_3 |
Clinical Clinical sync | 2026년 7월 12일 (1일 전) |
추천 비교
추천 비교